1. Home
  2. NISN vs PPCB Comparison

NISN vs PPCB Comparison

Compare NISN & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NiSun International Enterprise Development Group Co. Ltd.

NISN

NiSun International Enterprise Development Group Co. Ltd.

HOLD

Current Price

$0.98

Market Cap

5.0M

Sector

Industrials

ML Signal

HOLD

PPCB

Propanc Biopharma Inc.

N/A

Current Price

$0.22

Market Cap

5.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NISN
PPCB
Founded
2005
2007
Country
China
Australia
Employees
N/A
N/A
Industry
Metal Fabrications
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
5.7M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
NISN
PPCB
Price
$0.98
$0.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
33.0K
628.3K
Earning Date
04-28-2026
02-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$238,745,633.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.91
$0.20
52 Week High
$9.33
$13.25

Technical Indicators

Market Signals
Indicator
NISN
PPCB
Relative Strength Index (RSI) 22.30 27.01
Support Level $1.05 $0.24
Resistance Level $1.17 $0.40
Average True Range (ATR) 0.10 0.06
MACD 0.07 0.01
Stochastic Oscillator 2.94 7.08

Price Performance

Historical Comparison
NISN
PPCB

About NISN NiSun International Enterprise Development Group Co. Ltd.

NiSun International Enterprise Development Group Co Ltd is a provider of supply chain solutions and integrated financial services. Nisun is dedicated to providing professional supply chain solutions to Chinese and foreign enterprises and financial institutions. Through its subsidiaries, it is engaged in delivering supply chain solutions, and supply chain trading services to its customers across different industries. The company also provides financial solutions to small and mid-sized enterprises within the supply chain ecosystem. Using its fintech platforms, it provides various financing options, including supply chain financing, trade financing, and receivables financing. Geographically, its operations are predominantly focused on markets within the People's Republic of China.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: